It has been shown that chemotherapy itself, namely chemotherapy-caused cellular stress, can in some cases elicit NF-κB activation in gastric cancer cell lines, which supports cell survival leading to acquisition of chemoresistancy [23,24]. The gene discussed is NFKB1; the disease is gastric cancer.